Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rivaroxaban'

Rivaroxaban published presentations and documents on DocSlides.

Rivaroxaban compared with enoxaparin for the prevention of

Rivaroxaban compared with enoxaparin for the prevention of

  • luanne-stotts
  • 21 Slides

Alexander T Cohen . On behalf of the MAGELLAN Ste...

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

  • yoshiko-marsland
  • 25 Slides

(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

  • celsa-spraggs
  • 0 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

  • giovanna-bartolotta
  • 15 Slides

Rivaroxaban Plus Aspirin in Patients With and Wit...

Recent ACS: STEMI, NSTEMI, UA

Recent ACS: STEMI, NSTEMI, UA

  • danika-pritchard
  • 20 Slides

Stabilized 1-7 Days Post-Index Event. Exclusions:...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • debby-jeon
  • 46 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Novel Oral Anticoagulants

Novel Oral Anticoagulants

  • natalia-silvester
  • 88 Slides

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • ellena-manuel
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

R eal-world

R eal-world

  • liane-varnes
  • 20 Slides

EVI. dence. on . S. troke prevention . I. n pati...

New Oral Anticoagulant

New Oral Anticoagulant

  • mitsue-stanley
  • 80 Slides

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • giovanna-bartolotta
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

Stroke, Bleeding, and

Stroke, Bleeding, and

  • lois-ondreau
  • 7 Slides

Mortality Risks . in . Elderly Medicare Beneficia...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • alexa-scheidler
  • 0 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

CAD/PAD in Primary Care CV Risk in Stable Outpatients

CAD/PAD in Primary Care CV Risk in Stable Outpatients

  • stefany-barnette
  • 0 Slides

Stratified by Baseline CV Risk Category. Aspirin ...

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

  • yoshiko-marsland
  • 18 Slides

Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • stefany-barnette
  • 22 Slides

A ssessment of D ual antiplatelet therapy versus...

Ima A. Kusuma , MD, FIHA

Ima A. Kusuma , MD, FIHA

  • hirook
  • 33 Slides

“JIH. ” Hospital, Yogyakarta, Indonesia. The U...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • coursion
  • 22 Slides

R. ivaroxaban . I. n atrial . F. ibrillation patie...

Rivaroxaban in stable peripheral or carotid artery disease

Rivaroxaban in stable peripheral or carotid artery disease

  • basidell
  • 17 Slides

Sonia Anand, on . behalf of the COMPASS Steering C...

Thromboembolic protocols

Thromboembolic protocols

  • cecilia
  • 27 Slides

& safe anticoagulant prescribing. July 2020. D...

X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the

X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the

  • LittleMissPerfect
  • 1 Slides

rivaroxaban. group vs. 1.02% of the vitamin K ant...

MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,

MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,

  • HoneyBun
  • 1 Slides

VTE death. ) for . rivaroxaban. vs. . enoxaparin....

Review on NOACs Studies Dr.

Review on NOACs Studies Dr.

  • BlessedBeyondMeasure
  • 37 Slides

Kourosh. . Sadeghi. Tehran University of medical ...

Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding

Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding

  • kyle585
  • 20 Slides

Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....

Update on the New Oral Anticoagulants

Update on the New Oral Anticoagulants

  • sherrill-nordquist
  • 39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

Alexander G

Alexander G

  • min-jolicoeur
  • 35 Slides

G. . Turpie. Professor Emeritus of Medicine. McM...

Management of

Management of

  • marina-yarberry
  • 74 Slides

Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...

Oral anticoagulants in the 21

Oral anticoagulants in the 21

  • natalia-silvester
  • 50 Slides

st. century: A practical guide to using newer A...

Dodson Thompson, DO

Dodson Thompson, DO

  • lois-ondreau
  • 40 Slides

Northlakes. Community Clinic. Minong, WI. Novel ...

Update in the Perioperative and Emergency Management of Nov

Update in the Perioperative and Emergency Management of Nov

  • danika-pritchard
  • 47 Slides

Annelise Gallien, MD FRCPC. Moncton City Hospital...

The Novel Oral Anticoagulants

The Novel Oral Anticoagulants

  • tatyana-admore
  • 47 Slides

Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...

Trials and Tribulations in VTE:

Trials and Tribulations in VTE:

  • celsa-spraggs
  • 0 Slides

How Do Real-World Data Fit In? . Program Goals. V...

Pharmaceutical Management of Cardiac Medications:

Pharmaceutical Management of Cardiac Medications:

  • pamella-moone
  • 0 Slides

A Look at New Oral Anticoagulants. Linda Wing, . ...

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

  • faustina-dinatale
  • 0 Slides

Fred V. Plapp MD PhD. Pathology and Laboratory Me...

Sandy Bartlett, PhD, PharmD

Sandy Bartlett, PhD, PharmD

  • mitsue-stanley
  • 0 Slides

, . BCPS, BCCCP. Associate Professor | Department...

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

  • phoebe-click
  • 0 Slides

NOACS IN AF. Where Do We Stand With NOACs in AF ...

New Oral Anticoagulants: A Review

New Oral Anticoagulants: A Review

  • phoebe-click
  • 0 Slides

Babak Moini, MD. Veterans Affairs Hospital. Noon ...

Pharmacology of Anticoagulants

Pharmacology of Anticoagulants

  • conchita-marotz
  • 0 Slides

Nathan Culver, . PharmD. , BCPS. anticoagulant Me...

Anticoagulation and Thrombosis Management

Anticoagulation and Thrombosis Management

  • pasty-toler
  • 14 Slides

Anticoagulation and Thrombosis Management A Revie...

Bleeding and cancer risk in patients with vascular

Bleeding and cancer risk in patients with vascular

  • danika-pritchard
  • 17 Slides

Bleeding and cancer risk in patients with vascul...

Copyright © 2024 DocSlides. All Rights Reserved